|
Melton-Celsa, A R; Darnell, S C; O'Brien, A D (1996) Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice. Infect Immun 64:1569-76
|
|
Sandlin, R C; Goldberg, M B; Maurelli, A T (1996) Effect of O side-chain length and composition on the virulence of Shigella flexneri 2a. Mol Microbiol 22:63-73
|
|
Sandlin, R C; Lampel, K A; Keasler, S P et al. (1995) Avirulence of rough mutants of Shigella flexneri: requirement of O antigen for correct unipolar localization of IcsA in the bacterial outer membrane. Infect Immun 63:229-37
|
|
Samuel, J E; Gordon, V M (1994) Evidence that proteolytic separation of Shiga-like toxin type IIv A subunit into A1 and A2 subunits is not required for toxin activity. J Biol Chem 269:4853-9
|
|
Tesh, V L; Burris, J A; Owens, J W et al. (1993) Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect Immun 61:3392-402
|
|
Lindgren, S W; Melton, A R; O'Brien, A D (1993) Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model. Infect Immun 61:3832-42
|
|
Gordon, V M; Whipp, S C; Moon, H W et al. (1992) An enzymatic mutant of Shiga-like toxin II variant is a vaccine candidate for edema disease of swine. Infect Immun 60:485-90
|
